Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/1997
10/09/1997CA2250350A1 Bisarylcyclobutene derivates as cyclooxygenase inhibitors
10/09/1997CA2250231A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2250209A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
10/09/1997CA2250204A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2250203A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2250190A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2250154A1 Dimethyl-substituted cyclohexane diene derivatives
10/09/1997CA2249716A1 Inhibitor and stimulator of stem cell proliferation and uses thereof
10/09/1997CA2249665A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249650A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249645A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249641A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249617A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249607A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249605A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249604A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249603A1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors
10/09/1997CA2249599A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249559A1 Inhibitors of farnesyl-protein transferase
10/09/1997CA2249369A1 N-(2 oxoacetyl or sulphonyl)-pyrrolidine/piperidine-2-carboxylic acid derivatives with improved multi-drug resistance activity
10/09/1997CA2249206A1 Apo-2li and apo-3 apoptosis polypeptides
10/09/1997CA2248856A1 Improved tissue destruction in cryosurgery by use of thermal hysteresis proteins
10/09/1997CA2248729A1 Promotion of regeneration of organized tissues
10/09/1997CA2247996A1 Methods for treating bipolar mood disorder associated with markers on chromosome 18q
10/09/1997CA2222596A1 Protein with differentiation-inducing activity for friend's erythroleukemia cell lines
10/09/1997CA2220407A1 Diazepino-indoles as phosphodiesterase iv inhibitors
10/09/1997CA2201988A1 Heterocyclic .beta.-adrenergic agonists
10/08/1997EP0799619A2 Use of alpha1-adrenoreceptor antagonists in the manufacture of a medicament for the prevention and treatment of benign prostatic hyperplasia
10/08/1997EP0799315A2 Telomerase protein component
10/08/1997EP0799311A1 Human chemokine beta-9
10/08/1997EP0799309A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs
10/08/1997EP0799308A1 Tissue specific hypoxia regulated therapeutic constructs
10/08/1997EP0799238A2 14alpha,17alpha-c2-bridged 19-nor-progesterone derivatives
10/08/1997EP0799226A1 Tetracyclic spiro compounds, process for their preparation and their use as 5ht1d receptor antagonists
10/08/1997EP0799225A1 Compounds and methods
10/08/1997EP0799222A1 Piperazine 2,5 dione derivatives as modulators of multi-drug resistance
10/08/1997EP0799221A1 Quinazolines as inhibitors of endothelin converting enzyme
10/08/1997EP0799218A1 Diaryl-2-(5h)-furanones as cox-2 inhibitors
10/08/1997EP0799206A1 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists
10/08/1997EP0799205A1 1,4,4-(trisubstituted)cyclohex-1-ene derivatives as pde iv- and tnf-inhibitors
10/08/1997EP0799204A1 1,3,3-(trisubstituted)cyclohexane monomers and related compounds
10/08/1997EP0799200A1 Substituted azetidin-2-ones for treatment of atherosclerosis
10/08/1997EP0799198A1 Anti-inflammatory compounds
10/08/1997EP0799193A1 High purity n-(4-(n,n-bis(2-iodoethyl)amino]phenoscycarbonyl)-l-glutamic acid
10/08/1997EP0799191A1 Acetamidine derivatives and their use as inhibitors for the nitric oxide synthase
10/08/1997EP0799186A1 1,4,4-(trisubstituted)cyclohex-1-ene dimers and related compounds
10/08/1997EP0799185A1 1,3,3-(trisubstituted)cyclohexane dimers and related compounds
10/08/1997EP0799184A1 4,4-(disubstituted)cyclohexan-1-ol dimers and related compounds
10/08/1997EP0799182A1 3,3-(disubstituted)cyclohexan-1-ol dimers and related compounds
10/08/1997EP0799181A1 3,3-(disubstituted)cyclohexan-1-carboxylate dimers and related compounds
10/08/1997EP0799176A1 4,4-(disubstituted)cyclohexan-1-one dimers and related compounds
10/08/1997EP0799059A1 Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules
10/08/1997EP0799042A1 Compounds with progesterone-antagonistic and anti-oestrogen properties intended for combined use in female contraception
10/08/1997EP0799040A1 Trisubstituted thioxanthines
10/08/1997EP0799036A1 4,4-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds
10/08/1997EP0799033A1 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor
10/08/1997EP0799031A1 1,4,4-(trisubstituted)cyclohexane dimers and related compounds
10/08/1997EP0799023A1 Use of flavonoids as immunomodulating or immuno-protective agents in cosmetic and dermatological preparations
10/08/1997EP0799022A1 Use of flavonoids for protecting unstable cosmetic active substances and constituents in cosmetic and dermatological formulations
10/08/1997EP0799020A1 Cosmetic and dermatological preparations with flavonoids
10/08/1997EP0655062B1 Morpholino/thiomorpholino-terminated alkylamino ethynyl alanine amino diol compounds as renin inhibitors
10/08/1997EP0596118B1 Fr901451 substance, process for preparation thereof and use thereof
10/08/1997EP0580782B1 An anti-hiv protein, tap 29, from trichosanthes, dna coding therefor and therapeutic uses thereof
10/08/1997CN1161330A Substd. quinazoline derivatives
10/08/1997CN1161223A Placenta tonic medicines, the prepn. and application thereof
10/08/1997CN1036064C Method for preparing benzene derivatives with activity for improving the growth of NGF
10/07/1997US5675033 For treatment of skin disorders
10/07/1997US5675024 Retinoid receptor agonists
10/07/1997US5675008 Excitatory amino acid receptor antagonists
10/07/1997US5674998 C-4' modified adenosine kinase inhibitors
10/07/1997US5674988 Inhibition of influenza virus neuraminidase
10/07/1997US5674898 Methods and therapeutic compositions for treating cystic fibrosis
10/07/1997US5674893 Method for preventing reducing or risk of onset of cerebrovascular events employing an HMG CoA reductase inhibitor
10/07/1997US5674888 Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
10/07/1997US5674887 Prevention of bone resorption
10/07/1997US5674884 For treatment of serotonin-related disorders
10/07/1997US5674880 Tri-substituted phenyl derivatives and processes for their preparation
10/07/1997US5674868 Dimethylbenzofuran and dimethylbenzopyran derivatives and their use as 5-HT3 antagonists
10/07/1997US5674862 Methods of treating diabetic mellitus and its complications
10/07/1997US5674855 Intravenously administering protein- and peptide-free mixture containing cholanic acid or salt and a phospholipid
10/07/1997US5674853 Containing dietary polyunsaturated fatty acids and a saponin
10/07/1997US5674841 Method for inhibiting growth of stem cells
10/07/1997US5674708 Amino acid at position 358 is selected from the group consisting of isoleucine, valine, alanine, aspartic acid, threonine and glutamic acid
10/07/1997US5674497 Applying plant extract mixture for treatment of alopecia
10/07/1997US5674477 Reduction of hair growth
10/07/1997CA2004154C 3,5-di-tertiary-butyl-4-hydroxyphenyl-1,3,4-thiadiazoles, and oxadiazoles and 3,5-di-tertiary-butyl-4-hydroxyphenyl 1,2,4-thiadiazoles, oxadiazoles and triazoles as anti-inflammatory agents
10/07/1997CA1339488C De-n-acetyl-syalic acid and their applications as modifiers of cell physiology
10/02/1997WO1997035982A2 Monocyte chemotactic protein-5 materials and methods
10/02/1997WO1997035976A2 Epidermal differentiation factor
10/02/1997WO1997035971A1 A NOVEL MAMMALIAN GENE, bcl-w, BELONGS TO THE bcl-2 FAMILY OF APOPTOSIS-CONTROLLING GENES
10/02/1997WO1997035887A1 Precursors of catalytic antibodies
10/02/1997WO1997035885A1 ErbB3 ANTIBODIES
10/02/1997WO1997035873A2 Peptides with antiproliferative properties
10/02/1997WO1997035870A1 Growth factor htter36
10/02/1997WO1997035864A1 Phosphoramidates and phosphinic amides, their use to modulate the activity of endothelin
10/02/1997WO1997035862A1 Azaspiroderivatives
10/02/1997WO1997035861A1 Azaspiro derivatives
10/02/1997WO1997035858A1 4-[(THIEN-3-YL)METHYL] IMIDAZOLE DERIVATIVES HAVING α2-ADRENOCEPTOR AGONISTIC ACTIVITY
10/02/1997WO1997035857A1 4-[(thien-2-yl)methyl]imidazole derivatives having alpha2-adrenoceptor agonistic activity
10/02/1997WO1997035856A1 Novel treatment for cns injuries
1 ... 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 ... 1564